CYTO (Altamira Therapeutics) FCF Yield % : 271.03 (As of Dec. 12, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Altamira Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Altamira Therapeutics's Trailing 12-Month Free Cash Flow is $4.61 Mil, and Market Cap is $1.70 Mil. Therefore, Altamira Therapeutics's FCF Yield % for today is 271.03%.

The historical rank and industry rank for Altamira Therapeutics's FCF Yield % or its related term are showing as below:

CYTO' s FCF Yield % Range Over the Past 10 Years
Min: -98.21 Med: -33.4 Max: 260.33
Current: 271.03

During the past 13 years, the highest FCF Yield % of Altamira Therapeutics was 260.33%. The lowest was -98.21%. And the median was -33.40%.

CYTO's FCF Yield % is ranked better than
99.87% of 1507 companies
in the Biotechnology industry
Industry Median: -12.65 vs CYTO: 271.03

Altamira Therapeutics's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

Altamira Therapeutics FCF Yield % Historical Data

The historical data trend for Altamira Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altamira Therapeutics FCF Yield % Chart

Altamira Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-176.29

-27.40

-68.47

-204.04

-11.94

Altamira Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial															-180.12	-147.44	-330.72	304.01	-216.17

Competitive Comparison of Altamira Therapeutics's FCF Yield %

For the Biotechnology subindustry, Altamira Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altamira Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altamira Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Altamira Therapeutics's FCF Yield % falls into.

Altamira Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Altamira Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.614	/	5.1426744
	=	-11.94%

Altamira Therapeutics's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.204	*	2	/	2.9642772
	=	-216.17%

Altamira Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Altamira Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Altamira Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Altamira Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altamira Therapeutics Ltd (NAS:CYTO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM11

Website

https://www.altamiratherapeutics.com

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.